SPA
Sherbrooke Park Advisers Portfolio holdings
AUM
$230M
1-Year Return
0.33%
This Quarter Return
-9.86%
1 Year Return
-0.33%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$315M
AUM Growth
+$125M
(+65%)
Cap. Flow
+$132M
Cap. Flow
% of AUM
41.91%
Top 10 Holdings %
Top 10 Hldgs %
8.7%
Holding
642
New
313
Increased
103
Reduced
77
Closed
149
Top Buys
| 1 |
DTE Energy
DTE
|
+$2.94M |
| 2 |
Post Holdings
POST
|
+$2.68M |
| 3 |
Lockheed Martin
LMT
|
+$2.64M |
| 4 |
Coca-Cola
KO
|
+$2.53M |
| 5 |
McDonald's
MCD
|
+$2.47M |
Top Sells
| 1 |
McKesson
MCK
|
+$1.45M |
| 2 |
Consolidated Edison
ED
|
+$1.37M |
| 3 |
Element Solutions
ESI
|
+$1.34M |
| 4 |
Micron Technology
MU
|
+$1.33M |
| 5 |
Walmart
WMT
|
+$1.17M |
Sector Composition
| 1 | Technology | 18.18% |
| 2 | Industrials | 16.37% |
| 3 | Consumer Discretionary | 15.43% |
| 4 | Healthcare | 14.13% |
| 5 | Consumer Staples | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PGRE
426
Paramount Group
PGRE
$1.6B
| $144K | 0.05% |
+31,127
| New | +$144K |
|
427
Maravai LifeSciences
MRVI
$385M
| $143K | 0.05% |
+14,271
| New | +$143K |
|
|
MRNS
428
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $141K | 0.04% |
+17,539
| New | +$141K |
|
429
Emergent Biosolutions
EBS
$441M
| $141K | 0.04% |
+41,417
| New | +$141K |
|
430
Integral Ad Science
IAS
$1.42B
| $140K | 0.04% |
+11,800
| New | +$140K |
|
431
Utz Brands
UTZ
$1.13B
| $136K | 0.04% |
+10,146
| New | +$136K |
|
432
ADMA Biologics
ADMA
$3.91B
| $136K | 0.04% |
+37,944
| New | +$136K |
|
|
CIM
433
Chimera Investment
CIM
$1.18B
| $135K | 0.04% |
8,260
+1,268
| +18% | +$20.8K |
|
434
Upwork
UPWK
$2.12B
| $135K | 0.04% |
+11,864
| New | +$135K |
|
435
Alight
ALIT
$1.96B
| $134K | 0.04% |
+18,835
| New | +$134K |
|
436
Hillman Solutions
HLMN
$1.91B
| $129K | 0.04% |
+15,687
| New | +$129K |
|
437
Amplify Energy
AMPY
$155M
| $129K | 0.04% |
+17,569
| New | +$129K |
|
438
JetBlue
JBLU
$1.87B
| $124K | 0.04% |
26,864
+14,450
| +116% | +$66.5K |
|
439
Catalyst Pharmaceutical
CPRX
$2.45B
| $123K | 0.04% |
+10,544
| New | +$123K |
|
440
Ambac
AMBC
$424M
| $122K | 0.04% |
+10,100
| New | +$122K |
|
441
Gray Television
GTN
$597M
| $120K | 0.04% |
+17,307
| New | +$120K |
|
|
SBDS
442
Solo Brands, Inc.
SBDS
$23.2M
| $120K | 0.04% |
+23,450
| New | +$120K |
|
|
SWN
443
DELISTED
Southwestern Energy Company
SWN
| $114K | 0.04% |
+17,745
| New | +$114K |
|
|
AGTI
444
DELISTED
Agiliti, Inc.
AGTI
| $114K | 0.04% |
+17,623
| New | +$114K |
|
445
Enanta Pharmaceuticals
ENTA
$193M
| $113K | 0.04% |
+10,100
| New | +$113K |
|
446
Amcor
AMCR
$18.9B
| $113K | 0.04% |
+12,307
| New | +$113K |
|
|
AAN
447
DELISTED
The Aaron's Company, Inc.
AAN
| $109K | 0.03% |
+10,453
| New | +$109K |
|
448
MBIA
MBI
$382M
| $109K | 0.03% |
+15,094
| New | +$109K |
|
449
Avidity Biosciences
RNA
$6B
| $107K | 0.03% |
+16,769
| New | +$107K |
|
450
TG Therapeutics
TGTX
$5.08B
| $104K | 0.03% |
+12,415
| New | +$104K |
|